MHRA appoints senior NHS executive as new Chief Finance and Commercial Officer
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed a new Chief Financial and Commercial Officer to drive forward the financial aspects of its new five-year strategy.
Steven Davies
Steven Davies joins the MHRA from his current role as Chief Financial and Investment Officer at Guy’s and St. Thomas’ NHS Foundation Trust, one of the largest NHS organisations in the country.
Steven has substantial knowledge of the sector that the MHRA regulates, having worked in the NHS since starting the national finance graduate scheme in 2000. His 25 years’ experience also includes Moorfields Eye Hospital NHS Foundation Trust where he was Chief Financial Officer and Deputy Chief Executive.
At the MHRA, he will be responsible for leading the MHRA’s financial management, major investments and commercial plan, as it delivers on its recently published 2030 Strategy.
Lawrence Tallon, MHRA Chief Executive, said:
I’m delighted to welcome Steve to the MHRA. His deep financial and commercial expertise, and dynamic leadership style, will be invaluable as we set out to deliver our ambitious 2030 Strategy, with its associated revenue streams and capital investments in tech and labs. I look forward to working with Steve to optimise the funding model for innovators using MHRA services, and to design a regulatory framework that encourages inward investment to the UK life sciences industry.
Professor Anthony Harnden, MHRA Chair, said:
Steve’s financial leadership and commercial experience will help the MHRA to continue to deliver consistently high standards of performance. He will be an asset to the agency as we accelerate approvals, respond swiftly to emerging risks and ensure regulation keeps pace with scientific advances. I look forward to working with Steve.
Steven Davies, incoming MHRA Chief Finance and Commercial Officer said:
I’m hugely excited to be joining the MHRA as Chief Finance and Commercial Officer at such an important time. The Agency’s ambitious new strategy will bring real benefits for patients, innovators and the wider UK. Over the coming years, I look forward to working with colleagues across the Agency and partners across the health and life sciences system, to make sure the MHRA has the strong financial and commercial foundations it needs to deliver it.
Notes to editors
- The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe.
- The MHRA is an executive agency of the Department of Health and Social Care.
- For media enquiries, please contact newscentre@mhra.gov.uk or call 020 3080 7651.